Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Aznar

Showing results (61-70 of 111) with videos related to

Pageof 12
Sort By:
Haematologica|November 6, 2001
Evaluation of an automated method for the quantification of von Willebrand factor antigen. Its application in the study of vascular dysfunctionP Villa, J Iborra, J Serra, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 24, 2012
Assessment of the thrombin generation assay in haemophilia: comparative study between fresh and frozen platelet-rich plasmaV Vila, J A Aznar, A Moret, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 5, 2014
Inhibitor development after switching of FVIII concentrate in multitransfused patients with severe haemophilia AJ A Aznar, A Moret, F Ibáñez, et al.
Perception & Psychophysics|May 8, 2008
Can exocentric direction be dissociated from its exocentric distance in virtual environments?J A Aznar-Casanova, E H Matsushima, J A Da Silva, et al.
Sangre|January 1, 1977
[Assessment of circulating soluble fibrin by the ethanol test during delivery (author's transl)]A Tascon, J A Aznar, J R Mayans, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999
Zero incidence of inhibitor development in previously treated haemophilia A, HIV-negative patients upon exposure to a plasma-derived high-purity and double viral inactivated factor VIII concentrateJ A Aznar, J I Lorenzo, R Molina, et al.
Thrombosis Research|July 1, 1991
Detection of two different anti-factor VIII/von Willebrand factor antibodies of the IgA class in a hemophilic patient with a polyclonal factor VIII inhibitor of the IgG classE Carmona, J A Aznar, J I Jorquera, et al.
Sangre|January 1, 1985
[Anti-HTLV-III antibodies in hemophiliacs treated with concentrates of factors VIII or IX]J A Aznar, D Granda, J Jorquera, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 31, 2008
Inhibitors in haemophilia A: current management and open issuesS Haya, A Moret, A R Cid, et al.
Revista Clinica Espanola|August 1, 1978
[Local fibrinolysis in cerebral and subarachnoid hemorrhage]J J Vilchez, J A Aznar, J Benedito, et al.
Pageof 12

Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Haematologica|November 6, 2001
Evaluation of an automated method for the quantification of von Willebrand factor antigen. Its application in the study of vascular dysfunctionP Villa, J Iborra, J Serra, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 24, 2012
Assessment of the thrombin generation assay in haemophilia: comparative study between fresh and frozen platelet-rich plasmaV Vila, J A Aznar, A Moret, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 5, 2014
Inhibitor development after switching of FVIII concentrate in multitransfused patients with severe haemophilia AJ A Aznar, A Moret, F Ibáñez, et al.
Perception & Psychophysics|May 8, 2008
Can exocentric direction be dissociated from its exocentric distance in virtual environments?J A Aznar-Casanova, E H Matsushima, J A Da Silva, et al.
Sangre|January 1, 1977
[Assessment of circulating soluble fibrin by the ethanol test during delivery (author's transl)]A Tascon, J A Aznar, J R Mayans, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999
Zero incidence of inhibitor development in previously treated haemophilia A, HIV-negative patients upon exposure to a plasma-derived high-purity and double viral inactivated factor VIII concentrateJ A Aznar, J I Lorenzo, R Molina, et al.
Thrombosis Research|July 1, 1991
Detection of two different anti-factor VIII/von Willebrand factor antibodies of the IgA class in a hemophilic patient with a polyclonal factor VIII inhibitor of the IgG classE Carmona, J A Aznar, J I Jorquera, et al.
Sangre|January 1, 1985
[Anti-HTLV-III antibodies in hemophiliacs treated with concentrates of factors VIII or IX]J A Aznar, D Granda, J Jorquera, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 31, 2008
Inhibitors in haemophilia A: current management and open issuesS Haya, A Moret, A R Cid, et al.
Revista Clinica Espanola|August 1, 1978
[Local fibrinolysis in cerebral and subarachnoid hemorrhage]J J Vilchez, J A Aznar, J Benedito, et al.
Pageof 12